Product NewsLife Sciences

ELRIG research and innovation 2022: KREX proteomic analysis for biomarker discovery

7 Jun 2022
ELRIG research and innovation 2022: KREX proteomic analysis for biomarker discovery

In this video, Sengenics describes the utility of autoantibodies (AAb) and discusses AAb technology. Watch to explore specific case studies for anti-drug antibody response with adalimumab, patient stratification in autoimmune diseases, some recent developments in Parkinson’s disease, and more.

Other videos from Sengenics

Links